Top Markets
#1 Black Phoenix Black Phoenix +824.20%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +25.37%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.97%
#4 Prom Prom +20.14%
#5 Magma Finance Magma Finance +19.82%
#6 SAFEcoin SAFEcoin +19.77%
#7 Beam Beam +18.79%
#8 pipedog pipedog +17.11%
#9 Bless Bless +17.08%
#10 YFSX YFSX +15.57%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Classificação em ações #6138
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Preço da ação
$154.04
Valor de mercado
$2.21B
Variação (1 dia)
-0.19%
Variação (1 ano)
172.88%
País
US
Negociar Palvella Therapeutics, Inc. (PVLA)

Categoria

Healthcare
Histórico de preços das ações de Palvella Therapeutics, Inc. (PVLA)
Preço de fecho mais alto: $151.69 em 2026-08-01

Preço de fecho mais baixo: $13.11 em 2024-12-01
Histórico de preços das ações da Palvella Therapeutics, Inc. de 2024 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 7.48%
2025 649.84%
2024 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.65 40.75%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 49.04%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $143.63 472.23%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.19%
CH